Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, China.
Department of Obstetrics and Gynecology, Wenzhou People Hospital, Wenzhou, China.
BMC Pregnancy Childbirth. 2021 Sep 5;21(1):605. doi: 10.1186/s12884-021-04082-z.
D-dimer and fibrinogen were verified to be altered in preeclampsia. This study was to evaluate the associations of D-dimer and fibrinogen plasma levels with postpartum hemorrhage or intrauterine growth restriction in preeclamptic women.
This was a retrospective study that recruited 278 preeclamptic women with singleton pregnancy from January 2016 to December 2019. Patients were allocated into five groups: mild preeclampsia (mPE) (n=68), mild preeclampsia with postpartum hemorrhage (mPE+PPH) (n=13), severe preeclampsia (sPE) (n=112), severe preeclampsia with postpartum hemorrhage (sPE+PPH) (n=17) and severe preeclampsia with intrauterine growth restriction (sPE+IUGR) (n=68). The antenatal D-dimer and fibrinogen plasma levels were analyzed among the groups. Logistic regression was used to determine the correlation between serum indexes and PPH or IUGR in preeclampsia.
The antenatal D-dimer plasma levels were significantly higher in the sPE+PPH group than that in the sPE group (2.02 μg/ml versus 1.37 μg/ml, P = 0.001), but there was no difference in fibrinogen. Elevated D-dimer was associated with PPH among severe preeclamptic women (adjusted odds ratio (aOR) [95% CI]: 3.093 [1.527-6.264], P = 0.002). No differences in D-dimer and fibrinogen were found between the mPE and mPE+PPH groups or between the sPE and sPE+IUGR groups.
Elevated antenatal plasma D-dimer level may be associated with postpartum hemorrhage in severe preeclampsia, but not with intrauterine growth restriction. Future prospective clinical trials are needed to investigate the predictive value of D-dimer in postpartum hemorrhage in severe preeclampsia.
D-二聚体和纤维蛋白原已被证实可在子痫前期中发生改变。本研究旨在评估子痫前期妇女的 D-二聚体和纤维蛋白原血浆水平与产后出血或宫内生长受限的关系。
这是一项回顾性研究,纳入了 2016 年 1 月至 2019 年 12 月期间的 278 例患有单胎妊娠的子痫前期患者。患者被分为五组:轻度子痫前期(mPE)(n=68)、轻度子痫前期伴产后出血(mPE+PPH)(n=13)、重度子痫前期(sPE)(n=112)、重度子痫前期伴产后出血(sPE+PPH)(n=17)和重度子痫前期伴宫内生长受限(sPE+IUGR)(n=68)。分析各组孕妇的产前 D-二聚体和纤维蛋白原血浆水平。采用 Logistic 回归分析子痫前期血清指标与 PPH 或 IUGR 的相关性。
sPE+PPH 组的产前 D-二聚体血浆水平显著高于 sPE 组(2.02μg/ml 比 1.37μg/ml,P=0.001),而纤维蛋白原则无差异。在重度子痫前期妇女中,D-二聚体升高与 PPH 相关(调整后的优势比(aOR)[95%CI]:3.093[1.527-6.264],P=0.002)。mPE 和 mPE+PPH 组或 sPE 和 sPE+IUGR 组之间,D-二聚体和纤维蛋白原均无差异。
产前血浆 D-二聚体水平升高可能与重度子痫前期产后出血有关,但与宫内生长受限无关。未来需要前瞻性临床试验来研究 D-二聚体在重度子痫前期产后出血中的预测价值。